Aim & Scope
OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. Topics include: early stage clinical trials, detailed case reports dealing with molecular pathology, novel therapeutic regimens for improved benefit and/or decreased side effects, description of novel therapeutic targets and innovative agents. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients. [1]
2024 - VOLUME 17
No authors listed.
OncoTargets and Therapy2024 - VOLUME 17 pp 3-4.
0 2
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
LEF1-AS1, a long-noncoding RNA, promotes malignancy in glioblastoma.
J Wang , X Liu , C Yan , ... , P Zhao
OncoTargets and Therapy
2017 - VOLUME 10
23 35
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
No authors listed.
OncoTargets and Therapy2024 - VOLUME 17 pp 5-6.
0 4
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
TR Xing , P Chen , JM Wu , ... , LB Tong
OncoTargets and Therapy
2020 - VOLUME 13
13 29
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
C Xie , X Hao , H Yuan , ... , H Yu
OncoTargets and Therapy , 2024 - VOLUME 17 , pp 7-26.
No authors listed.
OncoTargets and Therapy2024 - VOLUME 17 pp 33-34.
0 2
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
J Guo , Y Li , H Duan , L Yuan
OncoTargets and Therapy
2020 - VOLUME 13
10 52
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
No authors listed.
OncoTargets and Therapy2024 - VOLUME 17 pp 35-36.
0 5
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
No authors listed.
OncoTargets and Therapy2024 - VOLUME 17 pp 37-38.
0 7
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression.
OncoTargets and Therapy
2021 - VOLUME 14
11 43
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
No authors listed.
OncoTargets and Therapy2024 - VOLUME 17 pp 39-40.
0 3
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
XS Liu , C Liu , YJ Chen , ... , ZJ Pei
OncoTargets and Therapy , 2024 - VOLUME 17 , pp 41-44.
Editorial Retractions, Expressions of Concern and External Notices
JK She , DN Fu , D Zhen , ... , B Zhang
OncoTargets and Therapy2020 - VOLUME 13 pp 9771-9783.
14 34
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
F Shen , X Pan , M Li , ... , J He
OncoTargets and Therapy2020 - VOLUME 13 pp 3165-3176.
17 26
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
Y Xin , W Zhang , C Mao , ... , Y Ren
OncoTargets and Therapy2020 - VOLUME 13 pp 1833-1844.
9 42
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
W Tao , Y Li , M Zhu , ... , P Li
OncoTargets and Therapy2019 - VOLUME 12 pp 8841-8851.
32 41
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
L Sun , S Yang , G Chi , X Jin
OncoTargets and Therapy2018 - VOLUME 11 pp 1583-1593.
4 33
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis.
S Chen , Y Liu , Y Wang , Z Xue
OncoTargets and Therapy2019 - VOLUME 12 pp 9215-9225.
22 32
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)